Pfizer Executives Changing Tune On Approach To Cancer
  • 6 years ago
NIAID / Flickr PFE Pfizer 35.68 -0.21 (-0.60 %) Disclaimer Get real-time PFE charts here " We're learning more about how a new class of cancer drugs that targets the body's immune system work in some patients, but not in others. Initially, the healthcare industry was really excited about seeing how pairing up two drugs that target the immune system work together to treat certain forms of cancer.
Recommended